Scott Tozier - Nov 8, 2021 Form 4 Insider Report for ALBEMARLE CORP (ALB)

Role
EVP & CFO
Signature
/s/ Stefanie M. Holland, Attorney-in-Fact
Stock symbol
ALB
Transactions as of
Nov 8, 2021
Transactions value $
-$8,000,167
Form type
4
Date filed
11/8/2021, 03:43 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALB Common Stock Options Exercise $792K +14K +25.06% $56.56 69.9K Nov 8, 2021 Direct
transaction ALB Common Stock Options Exercise $1.25M +22.3K +31.92% $56.08 92.2K Nov 8, 2021 Direct
transaction ALB Common Stock Sale -$847K -3.1K -3.36% $273.50 89.1K Nov 8, 2021 Direct F2
transaction ALB Common Stock Sale -$1.1M -4K -4.49% $274.39 85.1K Nov 8, 2021 Direct F3
transaction ALB Common Stock Sale -$850K -3.09K -3.63% $275.15 82K Nov 8, 2021 Direct F4
transaction ALB Common Stock Sale -$1.49M -5.38K -6.56% $276.42 76.7K Nov 8, 2021 Direct F5
transaction ALB Common Stock Sale -$5.26M -19K -24.73% $277.48 57.7K Nov 8, 2021 Direct F6
transaction ALB Common Stock Sale -$500K -1.8K -3.12% $278.05 55.9K Nov 8, 2021 Direct F7
holding ALB Common Stock 1.63K Nov 8, 2021 Albemarle Savings Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALB Stock Option Options Exercise $0 -14K -100% $0.00* 0 Nov 8, 2021 Common Stock 14K $56.56 Direct F8
transaction ALB Stock Option Options Exercise $0 -22.3K -100% $0.00* 0 Nov 8, 2021 Common Stock 22.3K $56.08 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan (the "Albemarle Savings Plan") as of the date of this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.81 to $273.80, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.83 to $274.81, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.85 to $275.71, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.855 to $276.83, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.885 to $277.88, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.895 to $278.23, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 On February 26, 2016, the reporting person was granted stock options for 14,010 shares of Common Stock. The option fully vested on 02/26/2019.
F9 On February 24, 2015, the reporting person was granted stock options for 22,320 shares of Common Stock. The options vested in three equal installments over three years: 02/24/2018, 02/24/2019, and 02/24/2020.